EX-FILING FEES 7 d390280dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form F-4

…………..

(Form Type)

Apollomics Inc.

……………………………………………………..

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security  
Type  
  Security Class  
Title  
  Fee  
Calculation  
or Carry  
Forward  
Rule  
  Amount  
Registered(1)(2)  
  Proposed  
Maximum  
Offering  
Price per  
Security  
  Maximum  
Aggregate  
Offering  
Price  
  Fee Rate     Amount of  
Registration  
Fee  
  Carry  
Forward  
Form  
Type  
  Carry  
Forward  
File  
Number  
  Carry  
Forward  
Initial  
Effective  
Date  
  Filing Fee  
Previously  
Paid In  
Connection  
with  
Unsold  
Securities  
to be  
Carried  
Forward  
 
Newly Registered Securities
                         
Fees to Be    
Paid    
  Equity     Class A Ordinary  
Shares (3)  
  Other     13,427,525  
Class A  
Ordinary  
Shares  
  $10.20(4)     $136,960,755     0.0001102     $15,093.08                  
  Equity     Warrants to  
purchase Class A  
Ordinary Shares(5)  
  Other     10,350,000  
Warrants  
  —     —     —     —                  
  Equity     Class A Ordinary  
Shares Underlying  
Warrants(6)  
  Other     10,350,000  
Class A  
Ordinary  
Shares  
  $11.58(7)     $119,853,000     0.0001102     $13,207.80                  
                         
    Equity     Class A Ordinary
Shares (8)    
  Other     3,100,000  
Class A  
Ordinary  
Shares  
  —     $103.33(9)     0.0001102     $0.01                  
                         
Fees    
Previously    
Paid    
  —     —     —     —     —     —     —     —                  
 
Carry Forward Securities
                         
Carry    
Forward    
Securities    
  —     —     —     —     —     —     —     —     —     —     —     —  
                   
    Total Offering Amounts       $256,813,858.33       $28,300.89                
                   
    Total Fees Previously Paid               $28,300.88                
                   
    Total Fee Offsets               $0.00                
                   
    Net Fee Due               $0.01                


  (1)

All securities being registered will be issued by Apollomics Inc., a Cayman Islands exempted company (“Apollomics”). In connection with the business combination (the “Business Combination”) described in this Registration Statement on Form F-4 (the “Registration Statement”) and the proxy statement/prospectus included herein, Maxpro Capital Acquisition Corp., a publicly traded Delaware corporation (“Maxpro”), will merge (the “Merger”) with and into Project Max SPAC Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Apollomics, with Maxpro surviving the merger. The number of Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), of Apollomics and the Class A Ordinary Shares issuable upon the exercise of warrants to purchase Class A Ordinary Shares (“Apollomics Warrants”) being registered is based upon the estimate of the sum of (i) the maximum number of shares of Class A common stock, par value $0.0001 per share (“Maxpro Class A Common Stock”), of Maxpro that will be outstanding immediately prior to the Business Combination and exchanged for an equal number of Class A Ordinary Shares (including the shares of Class B common stock (“Maxpro Class B Common Stock” and, together with the Maxpro Class A Common Stock, the “Maxpro Common Stock”) of Maxpro that will be converted to shares of Maxpro Class A Common Stock immediately prior to the Business Combination); and (ii) the maximum number of shares of Maxpro Class A Common Stock underlying each warrant of Maxpro (“Maxpro Warrants”), which will be assumed by Apollomics and will become Apollomics Warrants.

 

  (2)

Pursuant to Rule 416(a), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

 

  (3)

Represents Class A Ordinary Shares issuable in exchange for outstanding shares of Maxpro Common Stock upon the Merger.

 

  (4)

In accordance with Rule 457(c), based on the average of the high ($10.20) and low ($10.19) prices of the shares of Maxpro Class A Common Stock on The Nasdaq Global Market (“Nasdaq”) on November 17, 2022.

 

  (5)

Represents Apollomics Warrants, each whole warrant entitling the holder to purchase one Class A Ordinary Share, to be issued in exchange for warrants of Maxpro pursuant to the Business Combination.

 

  (6)

Represents Class A Ordinary Shares underlying the Apollomics Warrants.

 

  (7)

In accordance with Rule 457(f)(1), based on the sum of (a) the average of the high ($0.08) and low ($0.08) prices for the Maxpro Warrants on Nasdaq on November 17, 2022 and (b) $11.50, the exercise price of the Maxpro Warrants, resulting in a combined maximum offering price per warrant of $11.58. The maximum number of Class A Ordinary Shares issuable upon exercise of the Apollomics Warrants are being simultaneously registered hereunder. Consistent with the response to Question 240.06 of the Securities Act Rules Compliance and Disclosure Interpretations, the registration fee with respect to the Apollomics Warrants has been allocated to the underlying Class A Ordinary Shares and those Class A Ordinary Shares are included in the registration fee. The maximum number of Class A Ordinary Shares issuable upon exercise of the Apollomics Warrants are being simultaneously registered hereunder.

 

  (8)

Represents up to 3,100,000 Class A Ordinary Shares that may be issued to existing shareholders of Apollomics in connection with the Business Combination, at the sole discretion of Apollomics’ board of directors.

 

  (9)

Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(f)(2) based upon an amount equal to one-third of the par value of the securities held by existing shareholders of Apollomics to be exchanged in the Business Combination as of immediately prior to the Business Combination. Apollomics is a private company, no market currently exists for its securities and Apollomics has an accumulated capital deficit.

 

2